These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17060347)

  • 1. Prescribing of venlafaxine and dosulepin in primary care.
    McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
    J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
    Bukh JD; Jørgensen MB; Dam H; Plenge P
    Nord J Psychiatry; 2009; 63(4):347-51. PubMed ID: 19347769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic toxic syndrome with venlafaxine-desipramine combination.
    Benazzi F
    Pharmacopsychiatry; 1998 Jan; 31(1):36-7. PubMed ID: 9524985
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
    Mahapatra SN; Hackett D
    Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract]   [Full Text] [Related]  

  • 6. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 8. Venlafaxine drug-drug interactions in clinical practice.
    Benazzi F
    J Psychiatry Neurosci; 1998 May; 23(3):181-2. PubMed ID: 9595894
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.
    van den Broek WW; Mulder PG; van Os E; Birkenhäger TK; Pluijms E; Bruijn JA
    J Psychopharmacol; 2009 Aug; 23(6):708-13. PubMed ID: 18562424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: new preparation. Just another antidepressant.
    Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected antidepressant-induced switch to mania in unipolar depression: a first-person narrative.
    Amey C
    J Affect Disord; 2010 Sep; 125(1-3):111-5. PubMed ID: 20570368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
    Kok R; Nolen W; Heeren T
    Am J Geriatr Psychiatry; 2007 Aug; 15(8):725; author reply 726. PubMed ID: 17670999
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
    Conforti D; Borgherini G; Fiorellini Bernardis LA; Magni G
    Int Clin Psychopharmacol; 1999 May; 14(3):197-8. PubMed ID: 10435776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of venlafaxine in children and adolescents: a review of current literature.
    Weller EB; Weller RA; Davis GP
    Depress Anxiety; 2000; 12 Suppl 1():85-9. PubMed ID: 11098420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine and ecchymosis.
    Kohn S; Labbate LA
    Can J Psychiatry; 1997 Feb; 42(1):91. PubMed ID: 9040933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
    Krol DG; Nolen WA
    Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.
    Rubino A; Roskell N; Tennis P; Mines D; Weich S; Andrews E
    BMJ; 2007 Feb; 334(7587):242. PubMed ID: 17164297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.